NSE filing, NSE: ONESOURCE. Summary written from the filing by ALFA Finder's alert engine.
OneSource Specialty Pharma Ltd: key numbers
- Share price
- ₹1,571.00
- Market cap
- ₹18,015 Cr
- Revenue (annual)
- ₹1,422 Cr
- Net profit (annual)
- ₹-73.80 Cr
- P/E (TTM)
- -11113.5×Sector 46.5×
- Promoter holding
- 30.47%-0.01% QoQ
- FII holding
- 19.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from OneSource Specialty Pharma Ltd
All →OneSource Specialty Pharma Earnings Call Transcript: Key Takeaways
Onesource Specialty Pharma delivered its third consecutive growth quarter, driven by new sterile cartridge capacity.
OneSource Specialty Pharma Employee Stock Options
OneSource Specialty Pharma allotted 360 equity shares under its ESOP 2021 scheme to an eligible employee. Paid-up share capital increased to 11,46,74,151 shares of ₹1 each.
OneSource Specialty Pharma Management Change
Dr. Claudio Albrecht's designation changed from Independent Director to Non-Executive Non-Independent Director, effective 27 Oct 2026. The change is subject to shareholder approval at the upcoming meeting.
OneSource Specialty Pharma Q2 FY27 Results: Net Profit ₹57.5 Cr, Up 447.6% YoY
OneSource Specialty Pharma Ltd reported revenue from operations of ₹516.2 Cr (+37.4% YoY) and net profit of ₹57.5 Cr (+447.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹57.5 Cr · +447.6% YoY
OneSource Specialty Pharma Board Meeting Date
OneSource Specialty Pharma Limited scheduled a board meeting for October 27, 2026, to consider the company's unaudited financial results for the quarter ended September 2026.
OneSource Specialty Pharma Other Announcement
Onesource Specialty Pharma Ltd submitted its quarterly shareholding pattern in compliance with SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Other results update announcements
All →IIFL Capital Services Results Update
IIFL Capital Services reported consolidated Q2FY27 revenue of ₹722 crore, up 22% year-on-year, with PBT of ₹174 crore. The press release also covers the Fairfax change-in-control and a proposed NBFC subsidiary.
R R Kabel Results Update
R R Kabel's press release reports record half-year revenue, operating EBITDA and PAT for H1 FY27. Revenue rose 53% year-on-year, driven by wires and cables growth.
Gokul Agro Resources Results Update
Gokul Agro reported Q2FY27 revenue up 13% and PAT up 40% year on year. H1FY27 revenue rose 10%, with PAT up 54%.
Credent Connect N Care Results Update
Credent reported H1 FY27 consolidated revenue of ₹138.09 Crore (up 53.4%) and PAT of ₹14.65 Crore. It guides FY27 revenue of ₹320 Crore plus.
Pidilite Industries Results Update
Pidilite reported Q2 FY27 standalone net sales of Rs 3,982 crore, up 21.7%, with PAT up 10.4%. EBITDA margin was 20.4% after input cost headwinds.
Womancart Results Update
Womancart issued a Q2 and H1 FY27 press release reporting revenue and profit growth. Growth reflects an expanding product range and omnichannel presence.